PENNISI, MARIA STELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.364
EU - Europa 993
AS - Asia 702
SA - Sud America 193
AF - Africa 166
OC - Oceania 1
Totale 3.419
Nazione #
US - Stati Uniti d'America 1.325
RU - Federazione Russa 457
SG - Singapore 364
IT - Italia 253
BR - Brasile 175
CN - Cina 153
CI - Costa d'Avorio 113
IE - Irlanda 95
VN - Vietnam 57
DE - Germania 52
IN - India 49
SN - Senegal 35
GB - Regno Unito 29
CA - Canada 24
FI - Finlandia 23
JP - Giappone 13
BE - Belgio 12
MX - Messico 11
PL - Polonia 11
SE - Svezia 11
AR - Argentina 9
IQ - Iraq 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
ES - Italia 8
UZ - Uzbekistan 8
KR - Corea 7
TR - Turchia 7
BD - Bangladesh 6
HK - Hong Kong 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
FR - Francia 5
CH - Svizzera 4
NL - Olanda 4
NO - Norvegia 4
DO - Repubblica Dominicana 3
EC - Ecuador 3
ID - Indonesia 3
IL - Israele 3
MA - Marocco 3
CO - Colombia 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NG - Nigeria 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
GD - Grenada 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.419
Città #
Singapore 241
Moscow 223
Santa Clara 215
Dallas 212
Chandler 194
Abidjan 113
Chicago 101
Dublin 95
Ashburn 68
Catania 62
Beijing 49
Los Angeles 41
Civitanova Marche 34
Dakar 34
Kochi 32
Boardman 31
Cambridge 27
Lawrence 25
Andover 24
Grafing 23
Dong Ket 22
New York 21
Wilmington 17
Munich 16
São Paulo 15
The Dalles 15
Des Moines 14
Columbus 13
Montreal 13
Tokyo 13
Brussels 12
Council Bluffs 12
Ho Chi Minh City 12
Turku 12
Buffalo 11
Hefei 11
Palermo 11
Belo Horizonte 10
Hanoi 10
Nanjing 10
Santa Venerina 9
Brno 8
Helsinki 8
Johannesburg 8
Bari 7
Chennai 7
Seattle 7
Seoul 7
Toronto 7
Warsaw 7
Houston 6
Milan 6
Pune 6
Rio de Janeiro 6
Aci Catena 5
London 5
Bremen 4
Edinburgh 4
Falls Church 4
Frankfurt am Main 4
Giardini-Naxos 4
Hong Kong 4
Jiaxing 4
Manchester 4
Orem 4
Poplar 4
Querétaro 4
Saint Petersburg 4
Tashkent 4
Tremestieri Etneo 4
Baghdad 3
Boston 3
Catanzaro 3
Fantina 3
Guarulhos 3
Hanover 3
Jakarta 3
Jinan 3
Lappeenranta 3
Manaus 3
Messina 3
Oslo 3
Quảng Ngãi 3
San Giovanni la Punta 3
Stockholm 3
Volta Redonda 3
Woodbridge 3
Abuja 2
Amman 2
Amsterdam 2
Belém 2
Blumenau 2
Brasília 2
Brooklyn 2
Buenos Aires 2
Cabo Frio 2
Campo Grande 2
Casablanca 2
Comiso 2
Curitiba 2
Totale 2.356
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 208
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 158
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 157
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 147
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 147
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 145
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 144
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 144
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 140
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 137
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 135
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 134
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 132
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 128
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 127
New insights in thyroid cancer and p53 family proteins 118
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 115
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 111
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 111
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 105
Opportunities and challenges of liquid biopsy in thyroid cancer 104
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 98
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 97
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 96
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 93
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 93
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 92
The Role of New Technologies in Myeloproliferative Neoplasms 74
Totale 3.490
Categoria #
all - tutte 11.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/20261.290 97 94 230 127 277 465 0 0 0 0 0 0
Totale 3.490